title: A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
authors.affiliation: Dept. of Surgery, University of Pittsburgh School of Medicine, Pennsylvania 15213.
authors.forename: J
authors.initials: J
authors.lastname: Fung
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
authors.forename: A
authors.initials: A
authors.lastname: Jain
authors.forename: R
authors.initials: R
authors.lastname: Gordon
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
authors.forename: S
authors.initials: S
authors.lastname: Todo
authors.forename: S
authors.initials: S
authors.lastname: Takaya
authors.forename: M
authors.initials: M
authors.lastname: Alessiani
authors.forename: A
authors.initials: A
authors.lastname: Demetris
authors.forename: O
authors.initials: O
authors.lastname: Bronster
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone